A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
The medical community appears to be split over whether the UK has made the right decision in delaying the second Pfizer BioNTech vaccine dose from three weeks to 12, in order to administer more first doses of the vaccine to people who are at risk. The UK has become isolated from other countries in terms of vaccine policy, with most others vaccinating at either the intended three week interval or extending the interval to the World Health Organization recommended six weeks. 1 the bmj | BMJ 2021;372:n226 |doi:10.1136/bmj.n226 pmid:33495166 fatcat:zfawztzhqzerzbnir2q5ko3udq